{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:03:58Z","timestamp":1768975438642,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cardiology.theclinics.com","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ccl.2017.12.013","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T00:25:18Z","timestamp":1522455918000},"page":"317-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["High-Density Lipoproteins"],"prefix":"10.1016","volume":"36","author":[{"given":"Arash","family":"Haghikia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ccl.2017.12.013_bib1","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ccl.2017.12.013_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/emmm.201200224","article-title":"Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease","volume":"4","author":"Besler","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.2010-2378","article-title":"Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women","volume":"96","author":"Aron-Wisnewsky","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ccl.2017.12.013_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.113.301086","article-title":"Deficiency of ABCA1 and ABCG1 in macrophages increases inflammation and accelerates atherosclerosis in mice","author":"Westerterp","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"L\u00fcscher","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib7","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ccl.2017.12.013_bib8","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.CIR.0000159351.95399.50","article-title":"Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits","volume":"111","author":"Nicholls","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.RES.0000124302.20396.B7","article-title":"Reconstituted high-density lipoprotein inhibits thrombin-induced endothelial tissue factor expression through inhibition of RhoA and Stimulation of phosphatidylinositol 3-kinase but not akt\/endothelial nitric oxide synthase","volume":"94","author":"Viswambharan","year":"2004","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ccl.2017.12.013_bib11","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI16777","article-title":"HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner","volume":"111","author":"Gong","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib13","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI35470","article-title":"ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet","volume":"118","author":"Terasaka","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"25","key":"10.1016\/j.ccl.2017.12.013_bib14","doi-asserted-by":"crossref","first-page":"17947","DOI":"10.1074\/jbc.M112.442699","article-title":"High density lipoprotein protects against polymicrobe-induced sepsis in mice","volume":"288","author":"Guo","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"25","key":"10.1016\/j.ccl.2017.12.013_bib15","doi-asserted-by":"crossref","first-page":"22771","DOI":"10.1074\/jbc.M211032200","article-title":"Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1","volume":"278","author":"Vishnyakova","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00134-006-0433-x","article-title":"Lipoproteins in inflammation and sepsis. II. Clinical aspects","volume":"33","author":"Wendel","year":"2007","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.ccl.2017.12.013_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/ATVBAHA.108.183442","article-title":"Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity","volume":"29","author":"Wilhelm","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib18","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/ATVBAHA.111.234716","article-title":"Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice","volume":"31","author":"Feng","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ccl.2017.12.013_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4049\/jimmunol.1100253","article-title":"Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling","volume":"187","author":"Fessler","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"27","key":"10.1016\/j.ccl.2017.12.013_bib21","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.febslet.2008.10.006","article-title":"Lipid rafts and T-lymphocyte function: implications for autoimmunity","volume":"582","author":"Kabouridis","year":"2008","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.ccl.2017.12.013_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.semcdb.2007.07.009","article-title":"Lipid rafts and B cell signaling","volume":"18","author":"Gupta","year":"2007","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib23","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/ATVBAHA.108.168690","article-title":"High-density lipoprotein reduces the human monocyte inflammatory response","volume":"28","author":"Murphy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"17","key":"10.1016\/j.ccl.2017.12.013_bib24","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.1016086108","article-title":"HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells","volume":"108","author":"Feig","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5566","key":"10.1016\/j.ccl.2017.12.013_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ni.1939","article-title":"The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells","volume":"11","author":"Liu","year":"2010","journal-title":"Nat Immunol"},{"issue":"6341","key":"10.1016\/j.ccl.2017.12.013_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ccl.2017.12.013_bib28","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ccl.2017.12.013_bib29","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa011090","article-title":"Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease","volume":"345","author":"Brown","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ccl.2017.12.013_bib30","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2017.12.013_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Parish","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2017.12.013_bib32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ccl.2017.12.013_bib33","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ccl.2017.12.013_bib34","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.12.013_bib35","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccl.2017.12.013_bib36","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.jacc.2010.02.035","article-title":"RVX-208. A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in\u00a0vitro and in\u00a0vivo","volume":"55","author":"Bailey","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","article-title":"Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy","volume":"121","author":"Sorrentino","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2017.12.013_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1194\/jlr.M600167-JLR200","article-title":"Age-related impairment of HDL-mediated cholesterol efflux","volume":"48","author":"Berrougui","year":"2006","journal-title":"J\u00a0Lipid Res"},{"issue":"9","key":"10.1016\/j.ccl.2017.12.013_bib39","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI67478","article-title":"Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex","volume":"123","author":"Huang","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J\u00a0Lipid Res"},{"issue":"5","key":"10.1016\/j.ccl.2017.12.013_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.107.707349","article-title":"Endothelial lipase is increased in\u00a0vivo by inflammation in humans","volume":"117","author":"Badellino","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2017.12.013_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in\u00a0vivo","volume":"222","author":"de la Llera Moya","year":"2012","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ccl.2017.12.013_bib43","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ccl.2017.12.013_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11745-008-3169-2","article-title":"A\u00a0pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II","volume":"43","author":"Graversen","year":"2008","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.10.007","article-title":"Infection and inflammation decrease apolipoprotein M expression","volume":"199","author":"Feingold","year":"2008","journal-title":"Atherosclerosis"},{"issue":"23","key":"10.1016\/j.ccl.2017.12.013_bib46","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ccl.2017.12.013_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.ccl.2017.12.013_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ccl.2017.12.013_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib50","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1172\/JCI118589","article-title":"Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model","volume":"97","author":"Shih","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.ccl.2017.12.013_bib51","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ccl.2017.12.013_bib52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.CIR.0000023623.87083.4F","article-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","volume":"106","author":"Tward","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib54","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.299.11.1265","article-title":"Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk","volume":"299","author":"Bhattacharyya","year":"2008","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ccl.2017.12.013_bib55","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","article-title":"Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk","volume":"32","author":"Tang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.ccl.2017.12.013_bib56","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nm1637","article-title":"Protein carbamylation links inflammation, smoking, uremia and atherogenesis","volume":"13","author":"Wang","year":"2007","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.ccl.2017.12.013_bib57","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/eurheartj\/ehr193","article-title":"Myeloperoxidase deficiency preserves vasomotor function in humans","volume":"33","author":"Rudolph","year":"2012","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ccl.2017.12.013_bib58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"48","key":"10.1016\/j.ccl.2017.12.013_bib59","doi-asserted-by":"crossref","first-page":"46116","DOI":"10.1074\/jbc.M209124200","article-title":"Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation","volume":"277","author":"Zhang","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"45","key":"10.1016\/j.ccl.2017.12.013_bib60","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Urundhati","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200421109","article-title":"Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and function impairment in subjects with cardiovascular\u00a0disease","volume":"114","author":"Zheng","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1074\/jbc.M407019200","article-title":"Localization of nitration and chlorination sites on apolipoprotein A-I catalysed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages","volume":"280","author":"Zheng","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"38","key":"10.1016\/j.ccl.2017.12.013_bib63","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M503510200","article-title":"Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes","volume":"280","author":"Shiflett","year":"2005","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.ccl.2017.12.013_bib64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2013.02.009","article-title":"Abnormal high-density lipoprotein induces endothelial dysfunction via activation of toll-like receptor-2","volume":"38","author":"Speer","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ccl.2017.12.013_bib65","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1093\/ndt\/gfl292","article-title":"Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis","volume":"21","author":"Kielstein","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.ccl.2017.12.013_bib66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1096\/fj.04-3223fje","article-title":"Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension","volume":"19","author":"Pullamsetti","year":"2005","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.ccl.2017.12.013_bib67","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.2215\/CJN.01720211","article-title":"Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease","volume":"6","author":"Schepers","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ccl.2017.12.013_bib68","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ccl.2017.12.013_bib69","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1182\/blood-2010-09-304949","article-title":"Regulatory effects of TLR2 on megakaryocytic cell function","volume":"117","author":"Beaulieu","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ccl.2017.12.013_bib70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1165\/rcmb.2007-0010OC","article-title":"PKR regulates TLR2\/TLR4-dependent signaling in murine alveolar macrophages","volume":"38","author":"Cabanski","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.ccl.2017.12.013_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"issue":"9841","key":"10.1016\/j.ccl.2017.12.013_bib72","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ccl.2017.12.013_bib73","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.ccl.2017.12.013_bib74","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccl.2017.12.013_bib75","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"10.1016\/j.ccl.2017.12.013_bib76","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2017.12.013_bib77","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N\u00a0Engl J Med"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865117301637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865117301637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T20:14:01Z","timestamp":1570997641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865117301637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0733865117301637"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2017.12.013","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Density Lipoproteins","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2017.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}